STAT3 and neoplasm: Clinically, tumors with high STAT3 activity display poorer responses to FOLFOX, increased recurrence rates, and a more immunosuppressive tumor microenvironment characterized by M2 macrophage polarization and reduced CD8+ T-cell infiltration [24,25,43].